Genetic diversity of human immunodeficiency virus-1 isolates in Parana, Brazil

被引:8
|
作者
Michelon Toledo, Paula Virginia [1 ]
de Carvalho, Denisc Siqueira [1 ]
de Rossi, Silvia Gomes [1 ]
Brindeiro, Rodrigo [2 ]
de Queiroz-Telles, Flavio [1 ]
机构
[1] Univ Fed Parana, Curitiba, PR, Brazil
[2] Univ Fed Rio de Janeiro, Virol Lab, Rio De Janeiro, Brazil
来源
关键词
HIV-1; subtypes; genotype; antiretroviral; drug experienced patients; NON-B SUBTYPES; ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; HIV-1; PROTEASE; MOLECULAR CHARACTERIZATION; RESISTANCE MUTATION; TYPE-1; POLYMORPHISMS; INDIVIDUALS; IMPACT;
D O I
10.1590/S1413-86702010000300006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Because epidemiological data on circulating HIV subtypes among HIV-positive patients in the state of Parana were not known until now, the aims of this study were to describe the genetic diversity profile of HIV-1 in treated patients in Parana, Brazil, and report the differences in protease (PR) and reverse transcriptase (RT) mutations in HIV-1 subtypes. Patients and methods: A cross-sectional study was conducted from 2003 to 2006. Plasma viral RNA of 389 patients was extracted and PR and RT genes were polymerase chain reaction-amplified and sequenced. Sequences were subtyped and examined for antiretroviral resistance mutations. Data on gender of patient harboring the viruses and past history of antiretroviral treatment were also collected. Results: Most viruses were either subtype B (61.44%) or subtype C (20.57%). Subtype C and F were more frequent in women (p < 0.00). The prevalence of subtypes was similar over the years studied. The most frequent RT mutations in all subtypes were M184V and mutations at codons 215, 41, 103, 67, 219, and 190. Mutations 41L, 210W, 215YF, and 74V were significantly more prevalent on subtype B, and the mutation 106M was significantly more prevalent on subtype C. The most frequent major PI mutations in all subtypes occurred at codons 46, 82, and 90. PR mutations 32I, 46I, and 84V were significantly more prevalent on subtype B. The minor PI mutations on codons 36, 93, and 63 were more prevalent on subtypes F, C, and B, respectively. Conclusion: We concluded that the predominant strain of HIV-1 in Parana is subtype B, followed by subtype C. Some mutations at PR and TR had subtype predominance in accordance with other authors' report.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 50 条
  • [21] COINFECTION AND SYNERGY OF HUMAN IMMUNODEFICIENCY VIRUS-1 AND HERPES-SIMPLEX VIRUS-1
    HENG, MCY
    HENG, SY
    ALLEN, SG
    LANCET, 1994, 343 (8892): : 255 - 258
  • [22] Genetic diversity of human immunodeficiency virus-1 in Nigeria: 2002-2017-systematic review and meta-analysis
    Tahir, Mohammed Ibrahim
    Aminu, Maryam
    Suleiman, Babangida Ahmed
    Opaluwa, Ahmed Saraja
    Ahmad, Abdurrahman El-Fulaty
    NIGERIAN POSTGRADUATE MEDICAL JOURNAL, 2020, 27 (01) : 8 - 12
  • [23] EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS-1 IN HUMAN COLONIC CELLS
    KAGNOFF, MF
    OMARY, MB
    DEGRANDPRE, LY
    ROEBUCK, KA
    RICHMAN, DD
    BRENNER, DA
    IMMUNOLOGIC RESEARCH, 1991, 10 (3-4) : 452 - 455
  • [24] Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1
    McPherson, Tristan D.
    Sobieszczyk, Magdalena E.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 413 - 420
  • [25] Analysis of the human immunodeficiency virus-1 RNA packageome
    Eckwahl, Matthew J.
    Arnion, Helene
    Kharytonchyk, Siarhei
    Zang, Trinity
    Bieniasz, Paul D.
    Telesnitsky, Alice
    Wolin, Sandra L.
    RNA, 2016, 22 (08) : 1228 - 1238
  • [26] Polycythemia in patients infected with human immunodeficiency virus-1
    Koduri, PR
    Sherer, R
    Teter, C
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (01) : 80 - 81
  • [27] Group O human immunodeficiency virus-1 infections
    Jaffe, HW
    Schochetman, G
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1998, 12 (01) : 39 - +
  • [28] Finding a Cure for Human Immunodeficiency Virus-1 Infection
    Blankson, Joel N.
    Siliciano, Janet D.
    Siliciano, Robert F.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2014, 28 (04) : 633 - +
  • [29] Hydroxyurea to inhibit human immunodeficiency virus-1 replication
    Romanelli, F
    Pomeroy, C
    Smith, KM
    PHARMACOTHERAPY, 1999, 19 (02): : 196 - 204
  • [30] FLUORESCENCE SPECTROSCOPY OF HUMAN IMMUNODEFICIENCY VIRUS-1 REV
    NALIN, CM
    BIOPHYSICAL JOURNAL, 1990, 57 (02) : A51 - A51